Company: RNAC
Filing Date: 2025-01-08
Form Type: 424B7
Source: 0001140361-25-000634
Chunk: 24

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-01-08
Form: 424B7
Chunk 24
---
 or none of their Resale Shares. We do not know how long the Selling Stockholders will hold the Resale Shares before selling them, and we currently have no agreements, arrangements or understandings with the Selling Stockholders regarding the sale or other disposition of any of the Resale Shares. The Resale Shares covered hereby may be offered from time to time by the Selling Stockholders, provided that Resale Shares issued upon conversion of Series A Preferred Stock may only be offered after such shares of Series A Preferred Stock are converted to Common Stock pursuant to the terms of the Series A Certificate of Designation, subject to certain beneficial ownership limitations.

<div align='center'>18</div>

TABLE OF CONTENTS

The information set forth below is based upon information obtained from the Selling Stockholders and upon information in our possession regarding the issuance or potential issuance of the Merger Common Shares, Merger Conversion Shares, and Private Placement Conversion Shares. The percentages of Common Stock owned after the offering by each Selling Stockholder below are based on 25,725,306 shares of Common Stock outstanding as of November 22, 2024, and, for each Selling Stockholder, assumes the conversion of only the Series A Preferred Stock owned by such Selling Stockholder but not the Series A Preferred Stock owned by any other Selling Stockholder. The numbers of shares of Common Stock beneficially owned before and after the offering presented in the table below do not give effect to the Series A Beneficial Ownership Limitation.

| Name of Selling Stockholders(1)                        |     |       Common 
        Stock 
 Beneficially 
        Owned 
       Before 
  Offering(2) |     |      Common 
  Stock that 
         May 
  Be Offered 
 Pursuant to 
  Prospectus |     | Common Stock 
 Beneficially 
  Owned After 
  Offering(2) |     |            |
|                                                        |     |              |     |             |     |       Number |     | Percentage 
 (%)        |
| Entities affiliated with Timothy A. Springer, Ph.D.(3) |     |    9,481,816 |     |   4,957,015 |     |    4,524,801 |     | 17.5%      |
| Seven One Eight Three Four Irrevocable Trust(4)        |     |    6,435,335 |     |   6,435,335 |     |            — |     | —%         |

| (1) | To our